उत्पाद विवरण
Brestozol 1 mg Tablet is a potent aromatase inhibitor designed for the treatment of hormone receptor-positive breast cancer, particularly in its early stages. This medication is also utilized as a first-line therapy for advanced or metastatic breast cancer when the hormone receptor status is either positive or unknown, offering hope for improved outcomes in challenging cases. By inhibiting the aromatase enzyme, Brestozol effectively reduces estrogen levels in the body, which can slow or halt the growth of hormone-sensitive tumors. It is essential for patients to discuss their medical history with their healthcare provider, as Brestozol may not be suitable for everyone and can have potential interactions with other medications. Common side effects may include hot flashes, joint pain, and fatigue, which should be monitored throughout treatment. As with any cancer therapy, regular follow-ups are crucial to assess the effectiveness and manage any adverse effects. If you're considering Brestozol as part of your breast cancer treatment plan, consult with your oncologist to determine the best approach tailored to your individual needs.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese